1 / 50

Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D

Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D. Program Goals. Patient Case. How to Individualize Glycemic Targets. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy. 2013 AACE Glycemic Control Algorithm.

lucus
Download Presentation

Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Are All Incretin Therapies Alike? Maximizing Treatment Potential for Patients With T2D

  2. Program Goals

  3. Patient Case

  4. How to Individualize Glycemic Targets

  5. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

  6. 2013 AACE Glycemic Control Algorithm

  7. Exenatide Twice Daily vs Basal Insulin Hypoglycemia

  8. GLP-1 RAsEffects on Blood Pressure and Lipids

  9. DPP-4 Inhibitors as Add-on Therapy to Basal Insulin (With or Without Oral Agents)

  10. GLP-1 RAs vs DPP-4 Inhibitors Changes in HbA1c

  11. GLP-1 RAs vs DPP-4 InhibitorsChanges in FPG

More Related